Kenneth A Lichtenstein MD

  • Department of Medicine
  • Director, HIV Clinical and Research Program
Email
lichtensteink@njhealth.org
Gender
Male

Board Certified

Internal Medicine
Infectious Diseases

Research Interests

HIV-associated co-morbidities including lipodystrophy and cardiovascular disease

Service

Education & Training

Education

University of Colorado Denver
MD

Residencies

University of Colorado Affiliated Hospitals

Fellowships

University of Colorado Affiliated Hospitals

Awards & Recognition

Editorial Reviewer:
New England Journal of Medicine
Journal of AIDS
Clinical Infectious Diseases
Journal Infectious Diseases

Recent or Important Publications

Lichtenstein KA, Armon C, Moorman A, Buchacz K, Chmiel JS, Wood K, Brooks J, and the HOPS Investigators. Initiation of antiretroviral therapy at higher CD4+ T-cell counts reduces incidence of nucleoside analogue toxicities acutely and risk for later development with continued use of these agents in the HIV Outpatient (HOPS) cohort. In: Abstracts of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Sidney, Australia, July 22-25, 2007.

Overton T, Mondy K, Bush T, Conley L, Kojic E, Henry K, Hammer J, Wood K, Lichtenstein K, Brooks J, and the SUN Study Investigators. Factors Associated with Low Bone Mineral Density in a Large Cohort of HIV-Infected US Adults: Baseline Results from the SUN Study. Poster 836. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles. February 25-28, 2007.

Mondy K, Henry K, Overton T, Bush T, Conley L, Lichtenstein K, Kojic E, Mack W, Hodis H, Brooks J, and the SUN Study Investigators. Carotid Intima-media Thickness, Coronary Artery Calcium Scores, and Framingham Risk Scores among HIV-infected Patients in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy. Poster 810. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles. February 25-28, 2007.

Lichtenstein KA, Armon C, Buchacz K, Moorman A, Wood K, Brooks JT. Early, uninterrupted Antiretroviral Therapy Is Associated with Improved Outcomes and Fewer Toxicities in the HIV Outpatient Study. Poster 769. 13th Conference on Retroviruses and Opportunistic Infections, Denver. February 5-9, 2006.

Lichtenstein KA, Armon C, Buchacz K, Moorman A, Wood K, Brooks JT. Analysis of Cardiovascular Risk Factors in the HIV Outpatient Study Group. Poster 735. 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, February 5-9, 2006.

Curriculum Vitae

View Curriculum Vitae

Appointments


1-800-222-5864

Congratulations to Our 28 "Top Docs"


Twenty-eight physicians at National Jewish Health were named "Top Docs" in the annual ranking by 5280 magazine.
Learn more
.

Personalized Medicine


National Jewish Health is at the forefront of a new era in healthcare - personalized medicine.

Our science is truly transforming the lives of millions. Learn more.

Media Center


In the Media Center, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.